Altmayer P, Büch U, Büch H P
Clinic of Anesthesiology and Intensive Care Medicine, University of the Saarland, Homburg, Germany.
Arzneimittelforschung. 1995 Oct;45(10):1053-6.
The binding of the intravenous anesthetic propofol (CAS 2078-54-8) to human native plasma, hemoglobin and serum albumin was studied by means of equilibrium dialysis. Propofol binding to plasma over the large concentration range from 0.04 to 150 micrograms/ml was independent on the substrate concentration and amounted 97.4-98.6%. Serum albumin and hemoglobin also showed a marked binding for propofol. A 4% solution of albumin bound 88.7% and hemoglobin 86.2% of the anesthetic. In studies with constant protein concentration and variation of the propofol concentration a decrease of the percentage bound with increasing substrate concentration was seen for hemoglobin, indicating saturable binding sites. The opposite was found for the interaction between propofol and albumin: increase of the binding extent with increasing substrate concentration.
采用平衡透析法研究了静脉麻醉药丙泊酚(CAS 2078-54-8)与人天然血浆、血红蛋白和血清白蛋白的结合情况。在0.04至150微克/毫升的大浓度范围内,丙泊酚与血浆的结合不依赖于底物浓度,结合率为97.4-98.6%。血清白蛋白和血红蛋白对丙泊酚也有明显的结合。4%的白蛋白溶液结合了88.7%的麻醉药,血红蛋白结合了86.2%。在蛋白质浓度恒定且丙泊酚浓度变化的研究中,发现血红蛋白结合百分比随底物浓度增加而降低,表明存在可饱和的结合位点。丙泊酚与白蛋白之间的相互作用则相反:结合程度随底物浓度增加而增加。